Results 101 to 110 of about 504,545 (218)

Intramuscular Fat as a Biomarker of Muscle Health: Strengths, Limitations and Open Challenges

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 5, October 2026.
ABSTRACT Intramuscular fat (IMF), also known as myosteatosis, refers to the accumulation of lipids within and around skeletal muscle fibres. Excess IMF is increasingly recognised as a sign of poor muscle quality, linked to reductions in strength, power and mobility, and associated with adverse outcomes in metabolic disease, osteoarthritis ...
Christopher Spence   +4 more
wiley   +1 more source

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study

open access: yesPreventive Medicine Reports
Objective: This study examines the relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and sarcopenic obesity in U.S.
Jiao Liu, Fujue Ji, Jong-Hee Kim
doaj   +1 more source

One Size Fits None: Developing a Person‐Centered Approach to Weight Management in Older Adults

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Aruna V. Josyula   +6 more
wiley   +1 more source

Prevalence and Associated Factors of Sarcopenic Obesity Among Nursing Home Residents: A Cross‐Sectional Multi‐Centre Study

open access: yesJournal of Cachexia, Sarcopenia and Muscle
Background Obesity and sarcopenia are prevalent among older adults and associated with adverse health outcomes. The aims of the present study were to assess the prevalence of sarcopenic obesity, to evaluate the co‐occurence of sarcopenia, obesity and ...
Doris Eglseer   +6 more
doaj   +1 more source

Age‐ and Sex‐Specific Percentile Curves for the FM/FFM Ratio Using Data From the Canadian Longitudinal Study on Aging

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 5, October 2026.
ABSTRACT Background Sarcopenic obesity is associated with a significant increase in morbidity and mortality, particularly in older adults. Common measures of sarcopenic obesity consider obesity and sarcopenia independently, despite their potentially synergistic harmful effects.
Chris Kim   +2 more
wiley   +1 more source

Interleukin profile of patients with cataracts and sarcopenic obesity

open access: yesРоссийский офтальмологический журнал
The combination of cataracts and sarcopenic obesity is a common age-associated pathology with the involvement of interleukins as one of the leading pathogenetic mechanisms.
N. M. Agarkov   +3 more
doaj   +1 more source

Five‐Year CT‐Based Skeletal Muscle Decline Curves in Cirrhosis According to Liver Functional Reserve and Routinely Available Clinical Factors

open access: yesJGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Background Sarcopenia is common in cirrhosis and is associated with poor outcomes. We aimed to identify factors associated with longitudinal skeletal muscle loss and to explore estimation of future L3 skeletal muscle index (L3‐SMI) using routinely available clinical variables. Methods This retrospective longitudinal study included 175 patients
Suguru Miida   +14 more
wiley   +1 more source

Prevalence and Characteristics of Sarcopenic Obesity in Adults with Class II/III Obesity [PDF]

open access: yes, 2016
Adults with class II/III obesity (BMI ≥35 kg/m2) are at increased health risk, and may also present with lower lean mass in relation to excess adiposity, a condition termed sarcopenic obesity. A variety of body composition indices and cutpoints have been
Johnson Stoklossa, Carlene A.
core   +1 more source

Aging of Skeletal Muscle: From Molecular Mechanisms to Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Skeletal muscle aging is driven by coordinated local breakdown across myofibers, stem and stromal cells, immune and vascular compartments, and neuromuscular control. These mechanisms promote mitochondrial dysfunction, inflammation, senescence, impaired regeneration, fibrosis, myosteatosis, denervation, and functional decline.
Ting Liu, Yaomin Hu
wiley   +1 more source

A Systematic Review and Meta‐Analysis of Malnutrition and Metabolic Failure in High‐Potency Incretin Therapy

open access: yesObesity Science &Practice, Volume 12, Issue 5, October 2026.
ABSTRACT Objective High‐potency incretin therapy achieved substantial weight loss, but the extreme energy deficits it induced may obscure the underlying nutritional deterioration. This meta‐analysis synthesized data from 19 randomized trials across the SURMOUNT, STEP, SCALE, and OASIS programs to quantify the nutritional and body composition ...
Eugene Ampofo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy